Clinical Trials on Glabellar Crease in United Kingdom
Total 7462 results
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar Rhytides | Frown Lines Between the EyebrowsUnited States
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Advanced Cosmetic InterventionCompletedForehead Wrinkles | Glabellar FurrowingUnited States
-
Galderma R&DCompletedLateral Canthal Lines | Glabellar LinesUnited States, Puerto Rico
-
IpsenRecruitingModerate to Severe Glabellar LinesUnited States, Germany, France, Japan
-
Henry Ford Health SystemActive, not recruitingGlabellar Frown LinesUnited States
-
University of Southern CaliforniaActive, not recruitingGlabellar Frown LinesUnited States
-
AllerganCompletedFacial Rhytides | Glabellar RhytidesUnited States, Belgium, Germany, United Kingdom
-
Merz North America, Inc.Completed
-
AllerganCompletedGlabellar LinesUnited States, Canada, Brazil, France, Australia
-
Northwestern UniversityMedicis Pharmaceutical CorporationCompletedForehead/Glabellar Rhytid ComplexesUnited States
-
Galderma R&DCompletedGlabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)United States, Canada
-
Clinical Testing of Beverly HillsAllerganRecruitingGlabellar Frown LinesUnited States
-
Clinical Testing of Beverly HillsEvolus, Inc.Completed
-
Clinical Testing of Beverly HillsMerz North America, Inc.Not yet recruiting
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
AllerganCompletedGlabellar Rhytides | Forehead RhytidesUnited States, Canada, Ireland
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
Mead Johnson NutritionWithdrawnCow's Milk Allergy | Intolerance to Extensively Hydrolyzed Formulas | Intolerance to Breast MilkUnited Kingdom
-
AllerganCompletedGlabellar Lines | Nasolabial Fold | Crow's Feet Lines | Facial RhytidesUnited States
-
Merz North America, Inc.TerminatedGlabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper FaceUnited States
-
GC AestheticsRecruitingBreast Augmentation | Breast Reconstruction | Breast Reconstruction Following Mastectomy | Breast Reconstruction Surgery | Breast Implants | Breast Revision | Breast Reconstruction With Silicone Implants | Breast Reconstruction After MastectomyUnited Kingdom
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Royal Marsden NHS Foundation TrustRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerUnited Kingdom
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustRecruitingBreast Cancer | Triple Negative Breast Cancer | ER+ Breast Cancer | HER2+ Breast CancerUnited Kingdom
-
University College, LondonNorthwell Health; Capital Medical University; Scientific Center of ChildrenUnknownVolume of Breast Milk Expressed Using Single Electric Breast Pumps. | Duration of Exclusive Breast-feeding | Duration of Any Breast-feedingUnited Kingdom
-
Revance Therapeutics, Inc.CompletedUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)United States, Canada
-
University of the West of EnglandNIHR Research for Patient Benefit (RfPB)Completed
-
University of NottinghamUniversity of OxfordCompletedFamilial Breast CancerUnited Kingdom
-
Syantra Inc.Unknown
-
Cardiff UniversityWithdrawnMetastatic Breast CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomTerminatedMetastatic Breast CancerUnited Kingdom
-
ConcrRoyal Marsden NHS Foundation Trust; Institute of Cancer Research, United Kingdom and other collaboratorsEnrolling by invitationTriple Negative Breast Cancer | Cancer, Breast | Early-stage Breast CancerUnited Kingdom
-
Mayne Pharma International Pty LtdTerminatedLamellar IchthyosisUnited States, Spain, Canada, Germany, France, Australia, Israel, Ukraine, United Kingdom
-
Cambridge University Hospitals NHS Foundation TrustOxford University HospitalRecruitingBreast Surgery | Breast Neoplasms | Breast Carcinoma | Breast Reconstruction Surgery | Breast Cancer Early Stage Breast Cancer (Stage 1-3)United Kingdom
-
Imperial College LondonAstraZeneca; Natera, Inc.; SharpWithdrawnBreast Cancer | Oestrogen Receptor Positive Breast CancerUnited Kingdom
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIRCompletedBreast Cancer | Estrogen Receptor-positive Breast CancerUnited Kingdom
-
Imperial College LondonMedical Research Council; ECMCCompletedMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
Novartis PharmaceuticalsRecruitingBreast CancerUnited Kingdom
-
Barts & The London NHS TrustNot yet recruitingTriple Negative Breast Cancer (TNBC), Early SettingUnited Kingdom
-
University Hospitals of Derby and Burton NHS Foundation...CompletedBreast Cancer | Sentinel Lymph Node | Tattoo; Pigmentation | Axilla; BreastUnited Kingdom
-
Portsmouth Hospitals NHS TrustUniversity of PortsmouthRecruitingBreast Cancer PatientsUnited Kingdom
-
University of OxfordCancer Research UKActive, not recruitingBreast Cancer MortalityUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Enrolling by invitationBreast Cancer FemaleUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Breakthrough Breast CancerUnknown
-
Queen Mary University of LondonAstraZenecaRecruitingTriple Negative Breast CancerUnited Kingdom